The Dartmouth-Hitchcock Epilepsy Center is currently testing HOBSCOTCH in four epilepsy centers across New England. Participants include adults age 70 and under who have seizures and memory or cognitive symptoms.
Enrollment has already begun. Contact the epilepsy center nearest you to see if you qualify. Funding for this study is provided through the Centers for Disease Control and Prevention.
|Dartmouth-Hitchcock Medical Center
|Samantha S. Schmidt
|Maine Medical Center
|Anna C. Cloutier, RN, BSN, BA
|University of Massachusetts Medical School
|Barbara Glidden, CCRP
|University of Vermont Medical Center
|Lori J Fontneau
Dartmouth-Hitchcock Medical Center
- Barbara C. Jobst, MD, Principal Investigator
- Tracie A. Caller, MD, Co-Investigator
- Karen L. Secore, ARNP, RN, Co-Investigator
- Robert M. Roth, PhD, Co-Investigator
- Tor D Tosteson, ScD, Biostatistics
- Kimberly Birney, RN, Memory Coach
- Lindsay M. Schommer, APRN, MSN, Memory Coach
- Samantha S. Schmidt, Research Coordinator
- Faith Alexandre, Research Coordinator
Maine Medical Center
- Heidi L. Henninger, MD, Principal Investigator
- Mary Otis, RN, MS, Memory Coach
- Diana T. Page, ACNP, BC, Memory Coach
- Anna C. Cloutier, RN, BSN, BA, Research Coordinator
University of Massachusetts Medical School
- Felicia Chu, MD, Principal Investigator
- Catherine Phillips, MD, Co-Investigator
- Stephanie Pierce, NP, Memory Coach
- Daniel J. Weber, DO, Memory Coach
- Barbara Glidden, CCRP, Memory Coach
University of Vermont Medical Center
- Keith J. Nagle, MD, Principal Investigator
- Paul R. Jarvis, MD, Memory Coach
- Lori J. Fontneau, RN, Memory Coach/Research Coordinator
The HOBSCOTCH program was first evaluated as part of a feasibility study conducted at the Dartmouth-Hitchcock Epilepsy Center. This study suggested that a self-management intervention is feasible and can be effectively delivered over the telephone.
- Caller TA, Secore KL, Ferguson RJ, Roth RM, Alexandre FP, Henegan PL, Harrington JJ, & Jobst JC. (2015).Design and feasibility of a memory intervention with focus on self-management for cognitive impairment in epilepsy. Epilepsy & Behavior 44: 192-194.
The program was then evaluated in a randomized controlled trial which demonstrated that HOBSCOTCH improved quality of life as measured by the QOLIE-31 and also improved objective memory on a short neuropsychological battery.
- Caller TA, Secore KL, Ferguson RJ, Roth RM, Secore KL, Alexandre FP, Zhao W, Tosteson T,Henegan PL, Birney K & Jobst JC.(in press). A cognitive-behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy: a pilot study. Epilepsy & Behavior
A second randomized controlled trial is currently underway that will evaluate the feasibility and efficacy of HOBSCOTCH in a larger region in New England and whether HOBSCOTCH can be replicated and distributed to a larger patient population. In addition, a purely virtual version of HOBSCOTCH has been developed and is currently being evaluated.